by Prof. Ekaterina Dadachova, University of Saskatchewan, Canada
Radioimmunoimaging and radioimmunotherapy applications are supported by the MILabs VECTorCT platform at the University of Saskatchewan, including:
‣ Daratumumab-225Actinium Conjugate Demonstrates Greatly Enhanced Antitumor Activity Against Experimental Multiple Myeloma Tumors
‣ Comparative Radioimmunotherapy of Experimental Melanoma With Novel Humanized Antibody to Melanin Labeled With 213Bismuth and 177Lutetium
Took place: August, 2020 (at vEMIM)
Duwboot 7a
3991 CD Houten
The Netherlands
Phone: +31 85 088 5753
Fax: +31 88 756 0094
E-mail: [email protected]
REQUEST MORE INFORMATION
MILabs products are used in more than 65 countries and are supported by a global network of distributors and factory trained support engineers.
Please contact MILabs directly for more information about your local MILabs business partner.